Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

Shining a Spotlight on Early Career Researchers at the Symposium

Original source

Shining a Spotlight on Early Career Researchers at the SymposiumMotor Neurone Disease Association (UK) · 19 January 2024 (opens in a new tab)

Related topics

At the 34th International Symposium on ALS/MND, researchers presented laboratory findings on how toxic FUS and TDP-43 proteins may disrupt motor neurons. FUS interacted with 362 proteins at synapses, while toxic TDP-43 changed the activity of 146 proteins in motor neurons grown in the laboratory.

Why this matters

The findings identify cellular processes that researchers may investigate as possible treatment targets. They are early, mechanistic results and do not currently change treatment for people living with MND.

Limitations and context

This account comes from an organisational research blog describing symposium presentations, not from peer-reviewed primary research papers. The source does not provide full study methods, sample sizes or independent validation. The findings were obtained in laboratory models and need further investigation before their relevance to patients or treatments is known.

Summarised by Compass 9 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?